findmyKOL

Raksha Indorkar, MD

Basic profile

Cardiovascular Disease

ORCIDNone on fileNPI
RegionCleveland, OH · MidwestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2018Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Raksha Indorkar is a Cardiology physician. OpenAlex indexes 8 publications with 428 citations (h-index 3).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
8publications

Distinct works indexed by OpenAlex.

428citations

Total citations across indexed works.

3h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

11100 Euclid Ave
University Hospitals Case Medical Center
Cleveland, OH 44106

Telephone

216-844-8500

Provider last certified this registry record 24 Jun 2023.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    82.1%
    Beta blocker23.5%
    Metoprolol Succinate59%Carvedilol26%Metoprolol Tartrate14%
    Part D139 patients
    Statin10.7%
    Atorvastatin Calcium78%Rosuvastatin Calcium13%Pravastatin Sodium9%
    Part D88 patients

    + 14 more classes in this area

  • Blood & clotting

    11.9%
    Factor Xa inhibitor7.9%
    Eliquis66%Xarelto34%
    Part D49 patients
    Vitamin K antagonist2.6%
    Warfarin Sodium100%
    Part D24 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    6%
    SGLT2 inhibitor3.2%
    Jardiance61%Farxiga39%
    Part D<11 patients
    Potassium supplement2.7%
    Potassium Chloride87%Klor-Con M2013%
    Part D<11 patients
Where care is delivered (Part B)61% facility · 39% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”